Federated Hermes
ATNM icon

Federated Hermes’s Actinium Pharmaceuticals ATNM Stock Holding History

Federated Hermes’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134 Sell
137
-1,266
-90% -$1.46K ﹤0.01% 2033
2026
Q1 		$1.4K Hold
1,403
– – ﹤0.01% 1989
2025
Q4 		$1.91K Sell
1,403
-522
-27% -$762 ﹤0.01% 1969
2025
Q3 		$3.08K Sell
1,925
-3,396
-64% -$5.53K ﹤0.01% 1989
2025
Q2 		$7.45K Sell
5,321
-218
-4% -$326 ﹤0.01% 1853
2025
Q1 		$8.92K Buy
5,539
+2,796
+102% +$3.55K ﹤0.01% 1824
2024
Q4 		$3.46K Buy
2,743
+743
+37% +$1.15K ﹤0.01% 1928
2024
Q3 		$3.76K Buy
+2,000
New +$7.9K ﹤0.01% 1888

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Federated Hermes's ATNM Position: Q2 2026 in Review

Federated Hermes reduced its Actinium Pharmaceuticals (ATNM) stake by 90% in Q2 2026, selling an estimated $1.46K and leaving 137 shares worth $134. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Federated Hermes first reported a position in ATNM in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.92K in Q1 2025. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Federated Hermes held 137 shares of Actinium Pharmaceuticals worth $134 as of Q2 2026.
  • Federated Hermes sold 1,266 Actinium Pharmaceuticals shares in Q2 2026, an estimated $1.46K.
  • Actinium Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #2033 holding.
  • Federated Hermes first reported a position in Actinium Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Federated Hermes's Actinium Pharmaceuticals position peaked at $8.92K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.